YY1 and hepatocellular carcinoma: Despite the continuous improvement of medical technology in recent years, the mortality rate of hepatocellular carcinoma is still increasing due to the fact that most of the patients detected are in advanced stage.[39] YY1 binds to the MER52A promoter and promotes transcription.